Status: Not yet recruiting
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
This study will examine two doses of 1.0 mg and 2.0 mg of Semaglutide versus placebo in patients with Alcohol Use Disorder (AUD) and Obesity (Ob) to assess if these doses improve alcohol craving, stress and alcohol use outcomes.
Participants needed: 90
Trial details
Phase: Phase 1Age: 18-68Biological sex: AllType: InterventionalSponsor: Yale UniversityUpdated: Aug 19, 2026Locations: 1
Eligibility criteria
Male and females ages 18-60 and BMI in 30-49.9 kg/m2; [+5]
Meet current criteria for moderate to severe substance use disorders from abuse... [+10]